In adults with T2D, insulin icodec offers once-weekly therapy, reducing injection burden while providing effective glycemic control and simplified dosing.
Publication|Articles|October 19, 2026
- Fall 2026
- Volume 20
- Issue 2
The PharmD Is Not a Job Title: Building Career Optionality Before Graduation
Author(s)John Marc Tallegrand Jr, PharmD, RPh
Fact checked by: Tracy Ann Politowicz
Pharmacy students can create greater career optionality by viewing the PharmD as a professional platform rather than a predetermined job title.
Advertisement
Advertisement
Pharmacy school teaches students how to become pharmacists. That sounds obvious, but it hides a critical trap. Students spend years working toward a degree, completing rotations, preparing for licensure examinations, and eventually searching for employment.
Related to this article
AI tools in pharmacy education risk eroding critical thinking, lab competency, and patient safety if used as substitutes for foundational learning.
In an era of rapidly evolving technology, we remain in a people-powered world.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
A summer PCAC vote pushes 6 peptide families toward the 503A bulks list—but the FDA's decision is still pending.
Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
Pharmacists make a difference in patients’ lives through MTM services.
Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.
Advertisement
Advertisement